Resources search

Treatment of tuberculosis guidelines

WORLD HEALTH ORGANIZATION (WHO)
2010

Expand view

These guidelines aim ..."to help national tuberculosis (TB) control programmes in setting TB treatment policy to optimise patient cure: curing patients will prevent death, relapse, acquired drug resistance, and the spread of TB in the community. Their further purpose is to guide clinicians working in both public and private sectors." This new edition of the guidelines integrates the detection and treatment of both HIV infection and multi-drug resistant TB

Towards universal access : scaling up priority HIV/AIDS interventions in the health sector : progress report 2008

WORLD HEALTH ORGNAIZATION (WHO)
JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS)
UNITED NATIONS CHILDREN'S FUND (UNICEF)
2008

Expand view

This report provides in-depth information on: treatment and care for people living with HIV; HIV testing and counselling; health sector interventions for HIV prevention; scaling up HIV services for women and children; strengthening health systems and health information; and towards universal access as the way forward

TB/HIV : a clinical manual

HARRIS, Anthony D
MAHER, Dermot
2004

Expand view

Developments since 1996, particularly in the TB/HIV field, have prompted a second edition of this popular manual which provides a pocket-sized guide to the clinical management of TB, particularly in patients suffering from co-infection with HIV. Designed for use by busy clinicians, the manual aims to promote the best possible diagnosis and treatment in low-income countries where the prevalence of TB and HIV infection is high, case loads are heavy, and laboratory support may be limited. With these needs in mind, the manual combines the latest scientific knowledge about TB and HIV with authoritative advice based on extensive field experience in several of the hardest hit countries. Throughout the manual, tables, flow charts, lists of do's and don'ts, questions and answers, and numerous practical tips are used to facilitate quick reference and correct decisions. Information ranges from advice on how to distinguish TB from other HIV-related pulmonary diseases to the simple reminder that in sub-Saharan Africa, anyone with TB is in a high risk group for HIV. Though primarily addressed to clinicians working at district hospitals in sub-Saharan Africa, the manual is also suitable for use in areas of Asia and South America where the problem of TB and HIV co-infection poses a growing clinical challenge

Interim policy on collaborative TB/HIV issues

WORLD HEALTH ORGANIZATION (WHO). Stop TB Department and Department of HIV/AIDS
2004

Expand view

This policy responds to a demand from countries for immediate guidance on which collaborative TB/HIV activities to implement and under what circumstances. It is complementary to and in synergy with the established core activities of tuberculosis and HIV/AIDS prevention and control programmes. Implementing the DOTS strategy is the core activity for tuberculosis control. Similarly, infection and disease prevention and health promotion activities and the provision of treatment and care form the basis for HIV/AIDS control. This policy does not call for the institution of a new specialist or independent disease control programme. It rather promotes enhanced collaboration between tuberculosis and HIV/AIDS programmes in the provision of a continuum of quality care at service-delivery level for people with, or at risk of tuberculosis and people living with HIV/AIDS

Using knowledge management to make health systems work

BAILEY, Christopher
December 2003

Expand view

The discipline of knowledge management aims to bridge the gap between information availability and its communication in areas where the it is needed most. This editorial looks at two programmes that demonstrate how knowledge management can work

GDF drugs, diagnostics and other TB supplies

GLOBAL DRUG FACILITY (GDF)

Expand view

This catalogue lists first-line anti-TB drugs, TB diagnostics equipment and other products currently supplied by the Global Drug Facility (GDF). GDF is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to facilitate global DOTS expansion or maintenance to support the Stop TB Strategy

E-bulletin